Results 291 to 300 of about 1,301,037 (308)

PLASMINOGEN ACTIVATOR INHIBITOR IN PLASMA: RISK FACTOR FOR RECURRENT MYOCARDIAL INFARCTION

Lancet, The, 1987
exaly  

DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response

Nature, 2007
Akinori Takaoka, Hideyuki Yanai, Makoto Miyagishi   +2 more
exaly  

ISIS-3: a randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41 299 cases of suspected acute myocardial infarction

Lancet, The, 1992
exaly  

Endogenous tissue-type plasminogen activator and risk of myocardial infarction

Lancet, The, 1993
exaly  

Coronary Thrombolysis with Tissue-Type Plasminogen Activator in Patients with Evolving Myocardial Infarction

New England Journal of Medicine, 1984
Keith A A Fox
exaly  

Active Limb Activation

2012
openaire   +1 more source

Active Architects

Scientific American, 2021
openaire   +2 more sources

SPECIFIC LYSIS OF AN ILIOFEMORAL THROMBUS BY ADMINISTRATION OF EXTRINSIC (TISSUE-TYPE) PLASMINOGEN ACTIVATOR

Lancet, The, 1981
exaly  

Activation Analysis: Charged Particle Activation ☆

2018
Avino, Pasquale, Petrucci, Andrea, Strijckmans, Koen   +2 more
openaire   +2 more sources

Plasminogen-activator-inhibitor-1 4G/5G promoter polymorphism and prognosis of severely injured patients

Lancet, The, 2001
exaly